» Articles » PMID: 35147263

Bet V 1 Triggers Antiviral-type Immune Signalling in Birch-pollen-allergic Individuals

Overview
Date 2022 Feb 11
PMID 35147263
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In allergic patients, clinical symptoms caused by pollen remind of symptoms triggered by viral respiratory infections, which are also the main cause of asthmatic exacerbations. In patients sensitized to birch pollen, Bet v 1 is the major symptom-causing allergen. Immune mechanisms driving Bet v 1-related responses of human blood cells have not been fully characterized.

Objective: To characterize the immune response to Bet v 1 in peripheral blood in patients allergic to birch pollen.

Methods: The peripheral blood mononuclear cells of birch-allergic (n = 24) and non-allergic (n = 47) adolescents were stimulated ex-vivo followed by transcriptomic profiling. Systems-biology approaches were employed to decipher disease-relevant gene networks and deconvolution of associated cell populations.

Results: Solely in birch-allergic patients, co-expression analysis revealed activation of networks of innate immunity and antiviral signalling as the immediate response to Bet v 1 stimulation. Toll-like receptors and signal transducer transcription were the main drivers of gene expression patterns. Macrophages and dendritic cells were the main cell subsets responding to Bet v 1.

Conclusions And Clinical Relevance: In birch-pollen-allergic patients, the activated innate immune networks seem to be, in part, the same as those activated during viral infections. This tendency of the immune system to read pollens as viruses may provide new insight to allergy prevention and treatment.

Citing Articles

Common Pollen Modulate Immune Responses against Viral-Like Challenges in Airway Coculture Model.

Tossavainen T, Martikainen M, Loukola H, Roponen M J Immunol Res. 2023; 2023:6639092.

PMID: 37965270 PMC: 10643028. DOI: 10.1155/2023/6639092.


A short history from Karelia study to biodiversity and public health interventions.

Haahtela T, Alenius H, Auvinen P, Fyhrquist N, von Hertzen L, Jousilahti P Front Allergy. 2023; 4:1152927.

PMID: 36998574 PMC: 10043497. DOI: 10.3389/falgy.2023.1152927.


Immune modulation and COVID 19 in the Asia-Pacific region.

Shamji M, Boyle R Clin Exp Allergy. 2022; 52(8):922-923.

PMID: 35906962 PMC: 9353368. DOI: 10.1111/cea.14205.


Bet v 1 triggers antiviral-type immune signalling in birch-pollen-allergic individuals.

Wisgrill L, Fyhrquist N, Ndika J, Paalanen L, Berger A, Laatikainen T Clin Exp Allergy. 2022; 52(8):929-941.

PMID: 35147263 PMC: 9540660. DOI: 10.1111/cea.14108.

References
1.
Turunen R, Koistinen A, Vuorinen T, Arku B, Soderlund-Venermo M, Ruuskanen O . The first wheezing episode: respiratory virus etiology, atopic characteristics, and illness severity. Pediatr Allergy Immunol. 2014; 25(8):796-803. PMC: 7167827. DOI: 10.1111/pai.12318. View

2.
Saunders S, Ma E, Aranda C, Curotto de Lafaille M . Non-classical B Cell Memory of Allergic IgE Responses. Front Immunol. 2019; 10:715. PMC: 6498404. DOI: 10.3389/fimmu.2019.00715. View

3.
Calderon M, Demoly P, van Wijk R, Bousquet J, Sheikh A, Frew A . EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy. Clin Transl Allergy. 2012; 2(1):20. PMC: 3514324. DOI: 10.1186/2045-7022-2-20. View

4.
Upham J, Zhang G, Rate A, Yerkovich S, Kusel M, Sly P . Plasmacytoid dendritic cells during infancy are inversely associated with childhood respiratory tract infections and wheezing. J Allergy Clin Immunol. 2009; 124(4):707-13.e2. DOI: 10.1016/j.jaci.2009.07.009. View

5.
Wisgrill L, Fyhrquist N, Ndika J, Paalanen L, Berger A, Laatikainen T . Bet v 1 triggers antiviral-type immune signalling in birch-pollen-allergic individuals. Clin Exp Allergy. 2022; 52(8):929-941. PMC: 9540660. DOI: 10.1111/cea.14108. View